Generated August 28, 2026 at 8:31 PM ET
· Covers August 28 trading day
· 9 of 161 ready 8-Ks selected
· AI-assisted overview
The day's filings were dominated by Nasdaq delisting actions for GeoVax Labs (GOVX), Jupiter Neurosciences (JUNS), and BioAtla (BCAB), each citing bid price or equity compliance failures. M&A activity was prominent: Simulations Plus (SLP) shareholders approved an Altaris acquisition, Energy Fuels (UUUU) completed its acquisition of Australian Strategic Materials, and Karman Holdings (KRMN) closed the Walker Precision Engineering deal with new term loan financing. Getty Images (GETY) disclosed a $92.3M judgment in warrant litigation with an appeal and standstill agreement. BioXcel Therapeutics (BTAI) filed for Chapter 11 and agreed to sell assets to Teva, while Quoin Pharmaceuticals (QNRX) reported positive interim data and a capital raise.
regulatory
negative
materiality 0.90
August 28, 2026, 4:16 PM ET
GeoVax receives Nasdaq delisting notice over bid price; trading suspension expected Sept 8
- On Aug 27, 2026, Nasdaq Staff determined to delist GOVX common stock due to bid price below $1.00 for 30 consecutive trading days (Jul 16-Aug 26).
- 1-for-25 reverse split on Jan 12, 2026 makes company ineligible for 180-day compliance period under Rule 5810(c)(3)(A)(iv).
- Also previously non-compliant with $2.5M stockholders' equity requirement (Rule 5550(b)).
JUNS
JUPITER NEUROSCIENCES, INC.
regulatory
negative
materiality 0.90
August 28, 2026, 4:05 PM ET
Jupiter Neurosciences faces Nasdaq delisting; appeals; bid price compliance regained
- Received Nasdaq Staff notice on Aug 27, 2026 to delist common stock from Capital Market for failing to regain compliance with $35M market value requirement (Rule 5550(b)(2)) by Aug 25, 2026.
- Company intends to appeal to Nasdaq Hearings Panel; hearing request expected to stay delisting pending final determination.
- Regained compliance with $1.00 minimum bid price rule (5550(a)(2)) as of Aug 26, 2026; matter closed.
regulatory
negative
materiality 0.90
August 28, 2026, 8:01 AM ET
BioAtla faces Nasdaq delisting; trading to suspend Aug 31
- Nasdaq Listing Council affirmed delisting on Aug 26, 2026; suspension at open Aug 31, 2026.
- Delisting due to bid price below $1.00 and failure to meet $2.5M stockholders' equity requirement.
- Company expects OTC Markets quotation under ticker BCAB; liquidity and trading price may be materially affected.
SLP
Simulations Plus, Inc.
M&A
positive
materiality 0.85
August 28, 2026, 4:53 PM ET
Simulations Plus shareholders approve Altaris acquisition; pending French approval
- Special Meeting on Aug 27, 2026: 14,735,712 votes for vs 771,288 against to adopt merger with Altaris affiliate.
- Merger-related executive compensation approved 10,930,973 for vs 1,174,280 against; 3,434,284 abstained.
- Adjournment proposal passed 14,444,277 to 986,000; not needed since merger vote succeeded.
M&A
positive
materiality 0.80
August 28, 2026, 4:56 PM ET
Energy Fuels completes ~US$243M acquisition of Australian Strategic Materials via scheme
- On Aug 28, 2026, EFR subsidiary acquired all ASM ordinary shares; holders got 0.053 EFR CDIs/common shares + A$0.13 cash per share.
- Total consideration ~US$243.4M: US$217.2M in shares (14,808,572 new EFR shares) plus US$26.2M cash.
- ASM option holders received A$0.50 per option under concurrent scheme of arrangement.
GETY
Getty Images Holdings, Inc.
litigation
negative
materiality 0.85
August 28, 2026, 4:30 PM ET
Getty Images faces $92.3M judgment in warrant litigation; director resigns
- Director Chinh Chu resigned Aug 27, 2026 from Board and Compensation Committee; no disagreement cited.
- Court entered judgment of $92,306,578 (incl. interest) in Funicular Funds warrant suit; appeal filed Aug 26, 2026.
- Company and plaintiffs signed standstill agreement Aug 25, 2026; enforcement stayed 60 days; partial payment of ~$4,153,796.
KRMN
Karman Holdings Inc.
M&A
positive
materiality 0.75
August 28, 2026, 4:15 PM ET
Karman completes $95M Walker acquisition; adds $100M term loan
- Completed Walker Precision Engineering acquisition for ~$95M (£70M) cash on Aug 28, 2026.
- Sixth Amendment raised term loans by $100M to $863.961M; proceeds fund Walker deal and fees.
- Walker supports missile seekers/guidance on 25+ EU tactical missile, air and defense programs.
BTAI
BioXcel Therapeutics, Inc.
other material
negative
materiality 1.00
August 28, 2026, 6:00 AM ET
BioXcel files Chapter 11, sells assets to Teva for $57.5M upfront plus milestones
- Filed Chapter 11 petitions on Aug 27, 2026 in Delaware; operates as debtor-in-possession.
- DIP financing from Oaktree and QIA: up to $19M new money plus $58.25M roll-up.
- Stalking Horse APA with Teva: $57.5M upfront, up to $67.5M development milestones, up to $20M commercial milestones.
QNRX
Quoin Pharmaceuticals, Ltd.
other material
positive
materiality 0.90
August 28, 2026, 10:31 AM ET
Quoin reports positive QRX003 interim data, raises up to $50M in private placement
- Private placement up to $50M: $30.8M upfront at $4.88/ADS+warrant, 6,305,300 ADSs and warrants for 3,152,650 ADSs.
- Net proceeds ~$29M at Aug 31 close; funds into 2H 2029; proceeds for QRX003 development and general corporate.
- Phase 2/3 CL-QRX003-004: 4/6 (66.7%) met primary endpoint (≥1-grade IGA improvement), p=0.0087 vs α=0.0215.